Cdc42-Modified BMSC-Derived exosomes promote acellular nerve allografts to bridge sciatic nerve defects
Cell Transplantation · 2026-06 · 35
DOI: 10.1177/09636897261455558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Transplantation, online erschienen am 18.06.2026. Verfasst von Xin Sui und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Third Clinical College of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, P. R. China. Hauptthemen laut MEDLINE: Exosomes, cdc42 GTP-Binding Protein, Sciatic Nerve, Nerve Regeneration. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science Foundation of AMHT.
Abstract (Originalsprache)
Peripheral nerve injury (PNI) often results in persistent functional deficits, and current treatments remain suboptimal. This study developed a tissue-engineered graft by integrating Cdc42-modified bone marrow-derived mesenchymal stem cell (BMSC)-derived exosomes (Exos-Cdc42) with an acellular nerve allograft (ANA) and evaluated its therapeutic potential for nerve regeneration and functional recovery. Exosomes were isolated from BMSCs, and Exos-Cdc42 were generated by transfecting these cells with Cdc42 overexpression vectors. In vitro, Exos-Cdc42 significantly enhanced Schwann cell proliferation, migration, and secretion of neurotrophic factor (BDNF, NGF, CNTF), while upregulating repair-associated markers and downregulating myelination-related markers. In vivo, the combination of Exos-Cdc42 and ANA improved functional recovery of the sciatic nerve, as evidenced by higher sciatic functional index scores and increased muscle weight. Histological analyses demonstrated enhanced axonal regeneration and myelination, characterized by thicker myelin sheaths and larger axon diameters. These findings suggest that Exos-Cdc42 enhance the therapeutic efficacy of ANA by promoting Schwann cell-mediated repair responses, representing a promising strategy for peripheral nerve regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Third Clinical College of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, P. R. China.
- Department of Hand, Foot and Ankle Surgery, The Third Affiliated Hospital of Inner Mongolia Medical University, Baotou, Inner Mongolia Autonomous Region, P. R. China.
ORCID-Profile: Bo Feng
Förderung
- Science Foundation of AMHT
Zitieren
APA
Sui, X., Dai, G., & Feng, B. (2026). Cdc42-Modified BMSC-Derived exosomes promote acellular nerve allografts to bridge sciatic nerve defects. Cell Transplantation, 35. https://doi.org/10.1177/09636897261455558
Vancouver
Sui X, Dai G, Feng B. Cdc42-Modified BMSC-Derived exosomes promote acellular nerve allografts to bridge sciatic nerve defects. Cell Transplantation. 2026;35. doi:10.1177/09636897261455558
BibTeX
@article{Sui2026,
author = {Sui, Xin and Dai, Guangming and Feng, Bo},
title = {Cdc42-Modified BMSC-Derived exosomes promote acellular nerve allografts to bridge sciatic nerve defects},
journal = {Cell Transplantation},
year = {2026},
volume = {35},
doi = {10.1177/09636897261455558}
}
EUVIMED